2BB score and signals
Apogee Therapeutics, Inc.’s current 2BB score is 18 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 26 | Low |
| Momentum | 33 | Weakening |
| Financial strength | 21 | Weak |
| Quality | 100 | Very Strong |
| Risk | 35 | Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2022 |
| Employees | 261 |
| 52-week range | $35.39 – $134.99 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -1.1724 | — | $0.00 |
| 2026-08-10 | -1.14 | -1.0921 | $0.00 | $0.00 |
| 2026-05-11 | -1.06 | -1.1235 | $0.00 | $0.00 |
| 2026-03-02 | -1.03 | -1.0764 | $0.00 | $0.00 |
Related companies
